5-Hydroxytryptophol
|
Basic information |
| Metabolite name | 5-Hydroxytryptophol |
 | HMDB0001855 |
 |
N/A |
 |
9061 |
| Synonyms | 5-Hydroxyindole acetic acid; |
| No. of studies | 6 |
|
Basic information |
| Metabolite name | 5-Hydroxytryptophol |
| HMDB0001855 |
|
N/A |
|
9061 |
| Synonyms | 5-Hydroxyindole acetic acid; |
| No. of studies | 6 |
|
Relationship between 5-Hydroxytryptophol and depression (count: 6) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1004 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M1004 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Up |
| Study M1004 | Type1 | CUMS group vs. control group | Ileum | Sprague-Dawley rat | Up |
| Study M1004 | Type2 | CUMS + fluoxetine group vs. CUMS group | Ileum | Sprague-Dawley rat | Down |
| Study M1004 | Type2 | CUMS + fluoxetine group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M1004 | Type2 | CUMS + Zhi-Zi-Chi decoctions group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M1004 | Type2 | CUMS + Zhi-Zi-Chi decoctions group vs. CUMS group | Ileum | Sprague-Dawley rat | Down |
| Study M522 | Type1 | CUMS group vs. control group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M522 | Type2 | CUMS + NaP group vs. CUMS group | Prefrontal cortex | Sprague-Dawley rat | Up |
| Study M523 | Type1 | CUMS group vs. control group | Brain | Wistar rat | Down |
| Study M732 | Type1 | CUMS group vs. control group | Hippocampus | Sprague-Dawley rat | Down |
| Study M732 | Type1 | CUMS + high dose of propionate group vs. CUMS group | Hippocampus | Sprague-Dawley rat | Up |
| Study M758 | Type1 | CUMS group vs. control group | Ventral tegmental area | Sprague-Dawley rat | Down |
| Study M758 | Type1 | CUMS group vs. control group | Nucleus accumbens | Sprague-Dawley rat | Down |
| Study M758 | Type2 | CUMS + low dose of Shuganheweitang group vs. CUMS group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M758 | Type2 | CUMS + high dose of volatile oil group vs. CUMS group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M758 | Type2 | CUMS + high dose of terpenoid group vs. CUMS group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M758 | Type2 | CUMS + low dose of Shuganheweitang group vs. CUMS group | Nucleus accumbens | Sprague-Dawley rat | Up |
| Study M758 | Type2 | CUMS + fluoxetine group vs. CUMS group | Prefrontal cortex | Sprague-Dawley rat | Down |
| Study M758 | Type2 | CUMS + low dose of Shuganheweitang group vs. CUMS group | Ventral tegmental area | Sprague-Dawley rat | Up |
| Study M994 | Type1 | CUMS group vs. control group | Prefrontal cortex | C57BL/6 mouse | Down |
| Study M994 | Type1 | CUMS group vs. control group | Hippocampus | C57BL/6 mouse | Down |
| Study M994 | Type2 | CUMS + Uncaria rhynchophylla extract group vs. CUMS group | Prefrontal cortex | C57BL/6 mouse | Up |